Prophylactic uses of integrin CD18-βA peptide in a murine polymicrobial peritonitis model

by Wong, K.-F., Wo, J., Ho, D., Poon, R.T., Casasnovas, J.M., Luk, J.M.
Published 2014

Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

by Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
Published 2016

Global Regulation on microRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma

by Liu, A.M., Zhang, C., Burchard, J., Fan, S.T., Wong, K.-F., Dai, H., Poon, R.T., Luk, J.M.
Published 2014

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

by Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
Published 2014

Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90

by Lau, W.-Y., Sangro, B., Chen, P.-J., Cheng, S.-Q., Chow, P., Lee, R.-C., Leung, T., Han, K.-H., Poon, R.T.P.
Published 2014

Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)

by Sun, S., Poon, R.T.P., Lee, N.P., Yeung, C., Chan, K.L., Ng, I.O.L., Day, P.J.R., Luk, J.M.
Published 2016

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study

by Liu, A.M., Yao, T.-J., Wang, W., Wong, K.-F., Lee, N.P., Fan, S.T., Poon, R.T.P., Gao, C., Luk, J.M.
Published 2014

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma

by Xu, M.Z., Chan, S.W., Liu, A.M., Wong, K.F., Fan, S.T., Chen, J., Poon, R.T., Zender, L., Lowe, S.W., Hong, W., Luk, J.M.
Published 2014

Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma

by Wang Y., Shek F.H., Wong K.F., Liu L.X., Zhang X.Q., Yuan Y., Khin E., Hu M.-Y., Wang J.H., Poon R.T.P., Hong W., Lee N.P., Luk J.M.
Published 2019

Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma

by Cheng A., Thongprasert S., Lim H., Sukeepaisarnjaroen W., Yang T., Wu C., Chao Y., Chan S., Kudo M., Ikeda M., Kang Y., Pan H., Numata K., Han G., Balsara B., Zhang Y., Rodriguez A., Zhang Y., Wang Y., Poon R.
Published 2017

Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma

by Ivanovska, I., Zhang, C., Liu, A.M., Wong, K.F., Lee, N.P., Lewis, P., Philippar, U., Bansal, D., Buser, C., Scott, M., Mao, M., Poon, R.T.P., Fan, S.T., Cleary, M.A., Luk, J.M., Dai, H.
Published 2014

Oncofetal gene SALL4 in aggressive hepatocellular carcinoma

by Yong, K.J., Gao, C., Lim, J.S.J., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C.W., Wong, K.-F., Lee, S., Ravikumar, S., Srivastava, S., Tian, X., Poon, R.T., Fan, S.T., Luk, J.M., Dan, Y.Y., Salto-Tellez, M., Chai, L., Tenen, D.G.
Published 2014

Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker

by Chen, L., Ho, D.W.Y., Lee, N.P.Y., Sun, S., Lam, B., Wong, K.-F., Yi, X., Lau, G.K., Ng, E.W.Y., Poon, T.C.W., Lai, P.B.S., Cai, Z., Peng, J., Leng, X., Poon, R.T.P., Luk, J.M.
Published 2014

MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma

by Burchard, J., Zhang, C., Liu, A.M., Poon, R.T.P., Lee, N.P.Y., Wong, K.-F., Sham, P.C., Lam, B.Y., Ferguson, M.D., Tokiwa, G., Smith, R., Leeson, B., Beard, R., Lamb, J.R., Lim, L., Mao, M., Dai, H., Luk, J.M.
Published 2014

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

by Luk, J.M., Burchard, J., Zhang, C., Liu, A.M., Wong, K.F., Shek, F.H., Lee, N.P., Fan, S.T., Poon, R.T., Ivanovska, I., Philippar, U., Cleary, M.A., Buser, C.A., Shaw, P.M., Lee, C.-N., Tenen, D.G., Dai, H., Mao, M.
Published 2014

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

by Omata, M., Tateishi, R., Yoshida, H., Shiina, S., Lesmana, L.A., Budihusodo, U., Lesmana, C.R., Chen, P.-J., Lin, S.-M., Liaw, Y.F., Kudo, M., Lee, J.M., Choi, B.I., Poon, R.T.P., Cheng, A.L., Jia, J.-D., Obi, S., Han, K.H., Jafri, W., Chow, P., Lim, S.G., Chawla, Y.K., Gani, R.A., Putranto, T.A., Sarin, S.K.
Published 2011

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma

by Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N.P., Lee, W.H., Ariyaratne, P.N., Tennakoon, C., Mulawadi, F.H., Wong, K.F., Liu, A.M., Poon, R.T., Fan, S.T., Chan, K.L., Gong, Z., Hu, Y., Lin, Z., Wang, G., Zhang, Q., Barber, T.D., Chou, W.-C., Aggarwal, A., Hao, K., Zhou, W., Zhang, C., Hardwick, J., Buser, C., Xu, J., Kan, Z., Dai, H., Mao, M., Reinhard, C., Wang, J., Luk, J.M.
Published 2013

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma

by Kan, Z., Zheng, H., Liu, X., Li, S., Barber, T.D., Gong, Z., Gao, H., Hao, K., Willard, M.D., Xu, J., Hauptschein, R., Rejto, P.A., Fernandez, J., Wang, G., Zhang, Q., Wang, B., Chen, R., Wang, J., Lee, N.P., Zhou, W., Lin, Z., Peng, Z., Yi, K., Chen, S., Li, L., Fan, X., Yang, J., Ye, R., Ju, J., Wang, K., Estrella, H., Deng, S., Wei, P., Qiu, M., Wulur, I.H., Liu, J., Ehsani, M.E., Zhang, C., Loboda, A., Sung, W.K., Aggarwal, A., Poon, R.T., Fan, S.T., Wang, J., Hardwick, J., Reinhard, C., Dai, H., Li, Y., Luk, J.M., Mao, M.
Published 2014